tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GLMD Stock Latest News

Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice
Company AnnouncementsGalmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice
4d ago
6K
GLMD
Galmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications
PremiumCompany Announcements
Galmed Pharmaceuticals’ Aramchol Study: Key Updates and Market Implications
2M ago
GLMD
Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation
PremiumCompany Announcements
Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation
2M ago
6K
GLMD
Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
PremiumCompany Announcements
Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
2M ago
6K
GLMD
Galmed granted new Use Patent related to lead compound Aramchol
PremiumThe Fly
Galmed granted new Use Patent related to lead compound Aramchol
2M ago
GLMD
Galmed Pharmaceuticals Expands Aramchol’s Clinical Applications and Strengthens Financial Position
PremiumCompany AnnouncementsGalmed Pharmaceuticals Expands Aramchol’s Clinical Applications and Strengthens Financial Position
2M ago
6K
GLMD
Galmed issues CEO letter to shareholders
Premium
The Fly
Galmed issues CEO letter to shareholders
2M ago
GLMD
Galmed Pharmaceuticals Reports Q3 2025 Financials and Research Breakthroughs
Premium
Company Announcements
Galmed Pharmaceuticals Reports Q3 2025 Financials and Research Breakthroughs
2M ago
6K
GLMD
Galmed reports Q3 EPS (33c) vs. ($2.31) last year
PremiumThe Fly
Galmed reports Q3 EPS (33c) vs. ($2.31) last year
2M ago
GLMD
Galmed reports ‘meaningful’ results from AM-001 study of Aramchol meglumine
PremiumThe Fly
Galmed reports ‘meaningful’ results from AM-001 study of Aramchol meglumine
3M ago
GLMD
Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study
PremiumCompany Announcements
Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study
3M ago
6K
GLMD
Galmed Pharmaceuticals Reveals Promising Results in Oncology Drug Combination Study
PremiumCompany Announcements
Galmed Pharmaceuticals Reveals Promising Results in Oncology Drug Combination Study
3M ago
6K
GLMD
Galmed’s Aramchol and Bayer’s Stivarga show synergistic effect in GI cancers
PremiumThe FlyGalmed’s Aramchol and Bayer’s Stivarga show synergistic effect in GI cancers
3M ago
GLMD
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting
Premium
Company Announcements
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting
3M ago
6K
GLMD
Galmed Pharmaceuticals Reschedules Annual General Meeting Due to Lack of Quorum
Premium
Company Announcements
Galmed Pharmaceuticals Reschedules Annual General Meeting Due to Lack of Quorum
3M ago
6K
GLMD
Galmed Pharmaceuticals Schedules Annual General Meeting for October 2025
PremiumCompany Announcements
Galmed Pharmaceuticals Schedules Annual General Meeting for October 2025
5M ago
6K
GLMD
Galmed Pharmaceuticals Announces Q2 2025 Financial Results and Strategic Updates
PremiumCompany Announcements
Galmed Pharmaceuticals Announces Q2 2025 Financial Results and Strategic Updates
5M ago
6K
GLMD
Galmed Pharmaceuticals Unveils Digital Asset Strategy and Modifies SEDDS Agreement
PremiumCompany Announcements
Galmed Pharmaceuticals Unveils Digital Asset Strategy and Modifies SEDDS Agreement
5M ago
6K
GLMD
Galmed approves digital asset management strategy
PremiumThe Fly
Galmed approves digital asset management strategy
5M ago
GLMD
Galmed files to sell 7.5M shares of common stock for holders
PremiumThe FlyGalmed files to sell 7.5M shares of common stock for holders
6M ago
GLMD
Galmed Pharmaceuticals Amends Articles of Association Following Shareholder Approval
Premium
Company Announcements
Galmed Pharmaceuticals Amends Articles of Association Following Shareholder Approval
6M ago
6K
GLMD
Galmed Pharmaceuticals Reschedules Shareholder Meeting Due to Lack of Quorum
Premium
Company Announcements
Galmed Pharmaceuticals Reschedules Shareholder Meeting Due to Lack of Quorum
6M ago
6K
GLMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >